Old Web
English
Sign In
Acemap
>
authorDetail
>
Anne Floercken
Anne Floercken
Charité
Medicine
Oncology
Internal medicine
Renal cell carcinoma
in patient
4
Papers
10
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
AML: Negative Prognostic Impact of Early Blast Persistence Can be Overcome By Subsequent Remission Induction
2019
Blood
Jana Ihlow
Sophia Gross
Leonie Busack
Alma Herneth
I. W. Blau
Ioannis Anagnostopoulos
Michaela Schwarz
Anne Floercken
Lars Bullinger
Jörg Westermann
Show All
Source
Cite
Save
Citations (0)
Efficacy of fourth-line targeted therapy in patients with metastatic renal cell carcinoma: a retrospective analysis
2016
World Journal of Urology
Bernhard Ralla
Barbara Erber
Irena Goranova
Luise von der Aue
Anne Floercken
Stefan Hinz
Carsten Kempkensteffen
Ahmed Magheli
Kurt Miller
Jonas Busch
Show All
Source
Cite
Save
Citations (4)
In-Depth Quantitative Multiplex Proteomics Reveal Subtype-Specific Differences Among Functionally Validated AML Stem Cell Populations
2014
Blood
Simon Raffel
Jenny Hansson
Carl Herrmann
Christoph Lutz
Eike C. Buss
Christian Thiede
Anne Floercken
Oliver Bischel
Joerg Westermann
Gerhard Ehninger
Anthony D. Ho
Roland Eils
Jeroen Krijgsveld
Andreas Trumpp
Show All
Source
Cite
Save
Citations (0)
95 SEQUENTIAL USE OF TEMSIROLIMUS (TEM) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC): SAFETY AND EFFICACY FOLLOWING FAILURE OF RECEPTOR TYROSINE KINASE INHIBITOR (TKI) TREATMENT
2010
European Urology Supplements
Steffen Weikert
Carsten Kempkensteffen
K. Zimmermann
Viktor Grünwald
Anne Floercken
Jörg Westermann
K. Miller
Ulrich Keilholz
Manfred Johannsen
Show All
Source
Cite
Save
Citations (6)
1